Can eicosanoids cause localized vascular and neurovascular reactivity without raising hs-CRP?

Bioactive lipid mediators, specifically eicosanoids, serve as primary regulators of localized vascular and neurovascular reactivity. These molecules can drive significant changes in vascular tone and stability independently of systemic inflammatory markers like high-sensitivity C-reactive protein (hs-CRP).

Mechanisms of lipid-mediated reactivity

Eicosanoids are potent signaling molecules derived from arachidonic acid through three main enzymatic pathways: cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP).

• Vasoconstrictive mediators: Thromboxane A2 and leukotrienes (LTB4, LTE4) promote localized vasoconstriction and increase vascular permeability by inducing endothelial contraction.
• Neurovascular coupling: In the cerebral microcirculation, CYP450-derived eicosanoids such as 20-HETE and epoxyeicosatrienoic acids (EETs) modulate blood flow in response to neuronal activity. Specifically, 20-HETE acts as a powerful vasoconstrictor that regulates myogenic tone, while EETs generally promote vasodilation and neuroprotection.
• Localized action: These mediators typically act in a paracrine or autocrine fashion, exerting their effects on nearby smooth muscle and endothelial cells without entering systemic circulation in concentrations sufficient to trigger a generalized inflammatory response.

Dissociation from systemic inflammatory markers

The independence of localized lipid signaling from hs-CRP is rooted in their distinct biological pathways.

• Hepatic vs. local synthesis: hs-CRP is a protein synthesized primarily in the liver in response to systemic pro-inflammatory cytokines, specifically Interleukin-6 (IL-6).
• Evidence from vasomotor symptoms: In clinical studies of postmenopausal populations, neurovascular reactivity—manifesting as vasomotor symptoms—shows no consistent correlation with elevations in hs-CRP. This suggests that the transient, localized shifts in lipid mediators driving vascular instability do not necessarily reach the threshold required to stimulate the hepatic IL-6/CRP axis.
• Clinical implications: For older adults, localized neurovascular dysfunction or vascular hyper-reactivity may be present even when systemic biomarkers like hs-CRP remain within "low-risk" ranges (<1.0 mg/L).

Bottom line

Eicosanoids are essential, localized drivers of vascular and neurovascular tone. Because their activity is often site-specific and independent of the systemic cytokine-hepatic pathway, significant vascular reactivity can occur without an associated rise in hs-CRP levels.